137 related articles for article (PubMed ID: 12767263)
1. Expression and significance of new tumor suppressor gene PTEN in primary liver cancer.
Dong-Dong L; Xi-Ran Z; Xiang-Rong C
J Cell Mol Med; 2003; 7(1):67-71. PubMed ID: 12767263
[TBL] [Abstract][Full Text] [Related]
2. Expression and significance of a new tumor suppression gene PTEN in primary renal cell carcinoma.
Guo SP; Zhai YQ; Wang WL; Ma FC
Ai Zheng; 2002 Jun; 21(6):582-7. PubMed ID: 12452054
[TBL] [Abstract][Full Text] [Related]
3. [Expression of phosphatase and tensin homology deleted on chromosome ten(PTEN) and p53 protein and their significance in human hepatocellular carcinomas].
Cheng LM; Wang SY; Lin JS
Ai Zheng; 2003 Jan; 22(1):42-5. PubMed ID: 12561434
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
[TBL] [Abstract][Full Text] [Related]
5. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.
Rahman MA; Kyriazanos ID; Ono T; Yamanoi A; Kohno H; Tsuchiya M; Nagasue N
Int J Cancer; 2002 Jul; 100(2):152-7. PubMed ID: 12115563
[TBL] [Abstract][Full Text] [Related]
6. [PTEN expression and its significance in human primary hepatocellular carcinoma].
Wan XW; Wang HY; Jiang M; He YQ; Liu SQ; Cao HF; Qiu XH; Tang L; Wu MC
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):490-2. PubMed ID: 12939185
[TBL] [Abstract][Full Text] [Related]
7. [Expression of PTEN, Cx43, and VEGF in hepatocellular carcinoma].
Zhang TY; An JL; Gu JY; He S
Ai Zheng; 2004 Jun; 23(6):662-6. PubMed ID: 15191666
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of phosphorylated-Smad2 and PTEN in hepatocellular carcinomas and adjacent liver tissues].
Wu SK; Wang BJ; Yang Y; Tian YJ; Bao JJ; Feng XH; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):567-71. PubMed ID: 17711623
[TBL] [Abstract][Full Text] [Related]
9. The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma.
Wan XW; Jiang M; Cao HF; He YQ; Liu SQ; Qiu XH; Wu MC; Wang HY
J Cancer Res Clin Oncol; 2003 Feb; 129(2):100-6. PubMed ID: 12669234
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of PTEN and miR-92 in hepatocellular carcinoma.
Zhao B; Zhu Y; Cui K; Gao J; Yu F; Chen L; Li S
Mol Med Rep; 2013 May; 7(5):1413-6. PubMed ID: 23546593
[TBL] [Abstract][Full Text] [Related]
11. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
[TBL] [Abstract][Full Text] [Related]
12. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
[TBL] [Abstract][Full Text] [Related]
13. PTEN modulates insulin-like growth factor II (IGF-II)-mediated signaling; the protein phosphatase activity of PTEN downregulates IGF-II expression in hepatoma cells.
Kang-Park S; Lee YI; Lee YI
FEBS Lett; 2003 Jun; 545(2-3):203-8. PubMed ID: 12804776
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between the expression of PTEN protein and phosphorylation of MAPK in hepatocellular carcinomas and their surrounding liver tissues].
Feng DY; Cheng RX; Zheng H
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):117-20. PubMed ID: 12575334
[TBL] [Abstract][Full Text] [Related]
15. Expression of PTEN, PPM1A and P-Smad2 in hepatocellular carcinomas and adjacent liver tissues.
Wu SK; Wang BJ; Yang Y; Feng XH; Zhao XP; Yang DL
World J Gastroenterol; 2007 Sep; 13(34):4554-9. PubMed ID: 17729405
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of PTEN expression due to loss of promoter activity in human hepatocellular carcinoma cell lines.
Ma DZ; Xu Z; Liang YL; Su JM; Li ZX; Zhang W; Wang LY; Zha XL
World J Gastroenterol; 2005 Aug; 11(29):4472-7. PubMed ID: 16052674
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.
Horie Y; Suzuki A; Kataoka E; Sasaki T; Hamada K; Sasaki J; Mizuno K; Hasegawa G; Kishimoto H; Iizuka M; Naito M; Enomoto K; Watanabe S; Mak TW; Nakano T
J Clin Invest; 2004 Jun; 113(12):1774-83. PubMed ID: 15199412
[TBL] [Abstract][Full Text] [Related]
18. PTEN/MMAC1 mutations in hepatocellular carcinomas.
Yao YJ; Ping XL; Zhang H; Chen FF; Lee PK; Ahsan H; Chen CJ; Lee PH; Peacocke M; Santella RM; Tsou HC
Oncogene; 1999 May; 18(20):3181-5. PubMed ID: 10340391
[TBL] [Abstract][Full Text] [Related]
19. PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma.
Zhou X; Zhu H; Lu J
Pathol Res Pract; 2015 Apr; 211(4):316-9. PubMed ID: 25613699
[TBL] [Abstract][Full Text] [Related]
20. [The effects of PTEN gene on migration and FAK phosphorylation of SMMC-7721 human hepatocarcinoma cell line].
Zhang LN; Yu Q; Wang LY; Jin JW; Zha XL
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):161-6. PubMed ID: 12545224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
